September 07, 2023
Biochemical company Amyris Inc. Thursday received the go-ahead from a Delaware bankruptcy judge to reimburse up to $750,000 in attorney fees for an ad hoc group of creditors who hold nearly $450 million of Amyris' unsecured debt.
August 11, 2023
Biochemical company Amyris Inc. on Friday secured a debtor-in-possession loan of $190 million, all new money, from one of its lenders to fund an expedited Chapter 11 process, giving it 35 days to come up with a Chapter 11 plan all its creditors will approve.
August 10, 2023
Synthesized biologicals producer Amyris Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday, saying it needs to reorganize and sell off non-core businesses in the face of more than $1.1 billion in debt.